Edition:
India

Koninklijke Philips NV (PHG.AS)

PHG.AS on Amsterdam Stock Exchange

43.74EUR
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
€43.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,231,291
52-wk High
€44.45
52-wk Low
€29.05

Latest Key Developments (Source: Significant Developments)

Philips Signs Agreement To Create Digitalized Pathology Department In Taiwan
Thursday, 22 Aug 2019 

Aug 22 (Reuters) - Koninklijke Philips NV ::PHILIPS SIGNS AGREEMENT TO CREATE TAIWAN’S FIRST FULLY DIGITALIZED PATHOLOGY DEPARTMENT.  Full Article

Siemens Healthineers: We Don't Expect Philips To Intervene In Planned Acquisition Of Corindus
Wednesday, 7 Aug 2019 

Aug 8 (Reuters) - Siemens Healthineers ::SAYS WE DON'T EXPECT PHILIPS <<>> TO INTERVENE IN OUR PLANNED ACQUISITION OF CORINDUS <<>>.  Full Article

Philips Q2 Adjusted EBITA Beats Company-Compiled Poll
Monday, 22 Jul 2019 

July 22 (Reuters) - Koninklijke Philips NV ::PHILIPS DELIVERS Q2 SALES OF EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH AND 8% COMPARABLE ORDER INTAKE GROWTH; INCOME FROM CONTINUING OPERATIONS INCREASES TO EUR 260 MILLION AND ADJUSTED EBITA MARGIN IMPROVES TO 11.8%.WE CONTINUE TO EXPECT OUR PERFORMANCE MOMENTUM TO FURTHER IMPROVE IN SECOND HALF OF YEAR.SALES IN QUARTER AMOUNTED TO EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH.Q2 OPERATING CASH FLOW AMOUNTED TO EUR 390 MILLION, COMPARED TO EUR 130 MILLION IN Q2 2018; FREE CASH FLOW WAS EUR 174 MILLION.Q2 COMPARABLE ORDER INTAKE INCREASED 8%.WE MAINTAIN OUR OVERALL TARGETS FOR 2017-2020 PERIOD..Q2 INCOME FROM CONTINUING OPERATIONS INCREASED TO EUR 260 MILLION, COMPARED TO EUR 186 MILLION IN Q2 2018.Q2 EPS INCREASED AS INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.28;.Q2 ADJUSTED EBITA MARGIN WAS 11.8% OF SALES, COMPARED TO 11.2% OF SALES IN Q2 2018.Q2 ADJUSTED EPS INCREASED 23% AS ADJUSTED INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.43.Q2 INCOME FROM OPERATIONS INCREASED TO EUR 350 MILLION, COMPARED TO EUR 298 MILLION IN Q2 2018.Q2 ATTRIBUTABLE NET INCOME EUR 256 MILLION VERSUS EUR 239 MILLION IN COMPANY-COMPILED CONSENSUS.ADJUSTED EBITA MARGIN FOR GROUP IMPROVED BY 60 BASIS POINTS, MAINLY DRIVEN BY PERFORMANCE IMPROVEMENT OF DIAGNOSIS & TREATMENT BUSINESSES - CEO.Q2 ADJUSTED EBITA EUR 549 MLN VS EUR 542 MLN IN COMPANY-COMPILED CONSENSUS.  Full Article

Royal Philips Acquires Boston-Based Start-Up Company Medumo
Friday, 19 Jul 2019 

July 18 (Reuters) - Royal Philips::ROYAL PHILIPS - HAS EXPANDED ITS PATIENT MANAGEMENT SOLUTIONS IN U.S. WITH ACQUISITION OF BOSTON-BASED START-UP COMPANY MEDUMO.  Full Article

Philips Receives FDA Premarket Approval For Its HeartStart OnSite and HeartStart Home Defibrillators
Wednesday, 19 Jun 2019 

June 19 (Reuters) - Koninklijke Philips NV ::PHILIPS RECEIVES FDA PREMARKET APPROVAL FOR ITS HEARTSTART ONSITE AND HEARTSTART HOME DEFIBRILLATORS.  Full Article

Philips Says Stellarex.035 Demonstrated Safety In Clinical Trials At Three Years
Wednesday, 29 May 2019 

May 29 (Reuters) - KONINKLIJKE PHILIPS NV ::SAFETY AND EFFICACY OF PHILIPS’ STELLAREX .035 LOW-DOSE DRUG-COATED BALLOON DEMONSTRATED IN CLINICAL TRIALS AT THREE YEARS.ILLUMENATE PIVOTAL TRIAL SHOWCASES DURABLE PRIMARY PATENCY (MAINTAINED BLOOD FLOW) IN THE MOST COMPLEX PATIENT POOL STUDIED IN A DCB RANDOMIZED CLINICAL TRIAL.NO SIGNIFICANT DIFFERENCE IN MORTALITY COMPARED TO STANDARD OF CARE THROUGH THREE YEARS.STELLAREX IS ONLY LOW-DOSE DRUG-COATED BALLOON (DCB) TO DEMONSTRATE A SIGNIFICANT TREATMENT EFFECT AND HIGH SAFETY PROFILE THROUGH 3 YEARS.  Full Article

Philips And Vietnamese Hong Duc General Hospital Sign Multi-Year Strategic Partnership Agreement
Thursday, 11 Apr 2019 

April 11 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND VIETNAMESE HONG DUC GENERAL HOSPITAL SIGN MULTI-YEAR STRATEGIC PARTNERSHIP AGREEMENT.PHILIPS AND VIETNAMESE HONG DUC GENERAL HOSPITAL SIGN MULTI-YEAR STRATEGIC PARTNERSHIP AGREEMENT.  Full Article

Signify FY Net Income At 261 Million Euros
Friday, 1 Feb 2019 

Feb 1 (Reuters) - SIGNIFY NV ::SIGNIFY REPORTS FULL YEAR SALES OF EUR 6.4 BILLION, IMPROVEMENT IN OPERATIONAL PROFITABILITY BY 50 BPS TO 10.1% AND FREE CASH FLOW OF EUR 306 MILLION.FY LED-BASED SALES GREW BY 2.5% ON A COMPARABLE BASIS TO 71% OF SALES (FY 17: 65%); CSG TOTAL SIGNIFY -4.4%.FY REUTERS POLL: SALES EUR 6.41 BILLION; ADJUSTED EBITA EUR 632 MILLION; NET INCOME EUR 238 MILLION.FY ADJUSTED. INDIRECT COSTS DOWN EUR 224 MILLION ON A CURRENCY COMPARABLE BASIS, A REDUCTION OF 10%, OR 180 BPS OF SALES.2018 NET INCOME OF EUR 261 MILLION (FY 17: EUR 281 MILLION INCLUDING NET REAL ESTATE GAINS OF EUR 52 MILLION).FY ADJUSTED. EBITA MARGIN IMPROVED BY 50 BPS TO 10.1%, DESPITE A NEGATIVE CURRENCY IMPACT OF -50 BPS.FY FREE CASH FLOW OF EUR 306 MILLION.IN 2019, OUR GROWING PROFIT ENGINES (LED, PROFESSIONAL AND HOME COMBINED) ARE EXPECTED TO DELIVER A COMPARABLE SALES GROWTH IN RANGE OF 2 TO 5%.FY WORKING CAPITAL IMPROVED BY 20 BPS TO 8.4% OF SALES.OUR CASH ENGINE, LAMPS, IS EXPECTED TO DECLINE AT A SLOWER PACE THAN MARKET, IN RANGE OF -21 TO -24% ON A COMPARABLE BASIS.AIM TO REACH AN ADJUSTED EBITA MARGIN IN 2019 WITHIN RANGE OF 11 TO 13%.EXPECTS FREE CASH FLOW IN 2019 TO BE ABOVE 5% OF SALES.PROPOSES TO PAY A CASH DIVIDEND OF EUR 1.30 PER SHARE OVER 2018.WILL HAVE RETURNED EUR 1.1 BILLION TO SHAREHOLDERS SINCE IPO, INCLUDING 2018 DIVIDEND.  Full Article

Koninklijke Philips Collaborates With MIM Software
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS COLLABORATES WITH MIM SOFTWARE TO IMPROVE RADIATION THERAPY TREATMENT PLANNING.  Full Article

Koninklijke Philips Q4 Sales Amounted To 5.6 Billion Euros
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - KONINKLIJKE PHILIPS NV ::Q4 SALES AMOUNTED TO EUR 5.6 BILLION, WITH 5% COMPARABLE SALES GROWTH.Q4 OPERATING CASH FLOW INCREASED TO EUR 1,293 MILLION, COMPARED TO EUR 1,202 MILLION IN Q4 2017.Q4 INCOME FROM CONTINUING OPERATIONS INCREASED TO EUR 723 MILLION, COMPARED TO EUR 476 MILLION IN Q4 2017.  Full Article

Philips to sell remaining 10.7% stake in Signify for 357 million euros

AMSTERDAM Dutch medical equipment company Koninklijke Philips NV said on Thursday it plans to sell the remaining 10.7% stake it holds in Signify NV , its former lighting division, for about 357 million euros ($394.24 million) or 25.9 euros per share.